News | May 13, 2014

MR Solutions Showcases World’s First 7.0 Tesla Commercial, Cryogen Free, Preclinical System

May 13, 2014 — The world’s first commercial cryogen free, 7.0 Tesla, preclinical magnetic resonance imaging (MRI) system, 3.0 Tesla cryogen free preclinical benchtop MRI system and their other range of preclinical modalities, were displayed at MR Solutions booth at the joint International Society for Magnetic Resonance/ European Society for Magnetic Resonance in Medicine and Biology (ISMRM/ESMRMB) meeting on May 10, in Milan, Italy.

The 7.0 Tesla system, which has a bore of 17 centimeters, will be followed later in the year with a range of imaging systems with larger bore sizes.

Both the 3.0 Tesla and 7.0 Tesla systems can now be fitted with a state-of-the-art, clip-on single-photon emission computed tomography (SPECT) and positron emission tomography (PET) camera. 

MR Solutions has been able to dispense with the usual liquid helium cooling system by using a magnet design. This enables the use of a standard low temperature fridge to cool the magnet to the required 4 K (-269°C).

The magnet in the new 7.0 Tesla MRI system has an elliptical field of view, which makes it even more suitable for research purposes.

The new 7.0 Tesla systems, not only provides soft tissue contrast and molecular imaging capability, but because of its new design, it only takes the space of a large desk and therefore can be easily fitted in within an existing laboratory.

These technological advances have dramatically reduced the cost of these powerful systems to make them extremely competitive.

For more information: www.mrsolutions.com

Related Content

MRI Metal Artifact Reduction Poses Minimal Thermal Risk to Hip Arthroplasty Implants
News | Magnetic Resonance Imaging (MRI) | May 23, 2019
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
360 Photos | Magnetic Resonance Imaging (MRI) | May 17, 2019
This is a dedicated cardiac Siemens 1.5T MRI system installed at the Baylor Scott White Heart Hospital in Dallas.
Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition X 1.5T MRI
News | Magnetic Resonance Imaging (MRI) | May 17, 2019
Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition X 1.5T MR, the world’s...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing